Targeted therapies in rheumatoid arthritis - List of publications

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Targeted therapies in rheumatoid arthritis

Boumans, M.J.H.

Publication date

2012

Link to publication

Citation for published version (APA):

Boumans, M. J. H. (2012). Targeted therapies in rheumatoid arthritis.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

11

131

LIST OF PUBLICATIONS

1. Krausz S, Boumans MJ, Gerlag DM, Lufkin J, van Kuijk AW, Bakker A, de Boer M, Lodde BM, Reedquist KA, Jacobson EW, O’Meara M, Tak PP. A Phase IIA, Randomized, Double-Blind, Placebo-Controlled Trial of Apilimod Mesylate, an IL-12/IL-23 Inhibitor, in Patients with Rheumatoid Arthritis. Arthritis Rheum 2011 Dec 14. [Epub ahead of print]

2. Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann Rheum Dis 2012 Jan;71(1):108-13

3. Boumans MJ, Houbiers JG, Verschueren P, Ishikura H, Westhovens R, Brouwer E, Rojkovich B,

Kelly S, den Adel M, Isaacs J, Jacobs H, Gomez-Reino J, Holtkamp GM, Hastings A, Gerlag DM, Tak PP. Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Ann Rheum Dis 2011 Sep 14. [Epub ahead of print] 4. Boumans MJ, Vos K, Gerlag DM, Tak PP. Biological treatment of rheumatoid arthritis: towards

a more cost-effective re-treatment regimen using rituximab? Ann Rheum Dis 2011 Sep 8. [Epub ahead of print]

5. Boumans MJ, Thurlings RM, Gerlag DM, Vos K, Tak PP. Response to rituximab in patients with

rheumatoid arthritis in different compartments of the immune system. Arthritis Rheum 2011 Nov;63(11):3187-94

6. Gheorghe KR, Thurlings RM, Westman M, Boumans MJ, Malmström V, Trollmo C, Korotkova M, Jakobsson PJ, Tak PP. Prostaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expression.. PLoS One 2011 Jan 27;6(1):e16378 7. Van de Sande MG, Thurlings RM, Boumans MJ, Wijbrandts CA, Modesti MG, Gerlag DM,

Tak PP. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time? Ann Rheum Dis 2011 Apr;70(4):700-3

8. Thurlings RM, Boumans MJ, Tekstra J, van Roon JA, Vos K, van Westing DM, van Baarsen LG, Bos C, Kirou KA, Gerlag DM, Crow MK, Bijlsma JW, Verweij CL, Tak PP. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum 2010 Dec;62(12):3607-14

9. Kormelink TG, Tekstra J, Thurlings RM, Boumans MJ, Vos K, Tak PP, Bijlsma JW, Lafeber FP, Redegeld FA, van Roon JA. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis 2010 Dec;69(12):2137-44

10. Boumans MJ, Tak PP.Rituximab treatment in rheumatoid arthritis: how does it work? Arthritis Res Ther 2009;11(6):134

11. Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D.Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009 Apr;60(4):966-75